MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on April 29, 2008; DOI: 10.1124/mol.108.046623


0026-895X/08/7402-348-359$20.00
Mol Pharmacol 74:348-359, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.046623v1
74/2/348    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Dickinson, J. A.
Right arrow Articles by Wonnacott, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dickinson, J. A.
Right arrow Articles by Wonnacott, S.

Presynaptic {alpha}7- and β2-Containing Nicotinic Acetylcholine Receptors Modulate Excitatory Amino Acid Release from Rat Prefrontal Cortex Nerve Terminals via Distinct Cellular Mechanisms

Jane A. Dickinson, James N. C. Kew, and Susan Wonnacott

Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom (J.A.D., S.W.); and Psychiatry Discovery Technology Group, GlaxoSmithKline, Harlow, Essex, United Kingdom (J.N.C.K.)

Nicotine can enhance working memory and attention. Activation of both {alpha}7 and β2* nicotinic acetylcholine receptors (nAChRs) in the prefrontal cortex (PFC) has been implicated in these processes. The ability of presynaptic nAChRs to modulate neurotransmitter release, notably glutamate release, is postulated to contribute to nicotine's effects. We have examined the cellular mechanisms underlying {alpha}7 and β2* nAChR-mediated [3H]D-aspartate release from the PFC in vitro. Using the {alpha}7 and β2* nAChR-selective agonists (R)-N-(1-azabicyclo[2.2.2]-oct-3-yl)(5-(2-pyridyl)thiophene-2-carboxamide) (compound A) and 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine (5-iodo-A-85380), respectively, in conjunction with inhibitors of voltage-operated Ca2+ channels (VOCCs) and intracellular Ca2+ stores, we show that [3H]D-aspartate release evoked by activation of β2* nAChRs occurs via VOCCs. In contrast, {alpha}7 nAChR-evoked release was unaffected by VOCC blockers but was abolished by modulators of Ca2+ stores, including ryanodine. The {alpha}7 nAChR ligand {alpha}-bungarotoxin and ryanodine receptors were colocalized to a subpopulation of PFC synaptosomes. Compound A-evoked [3H]D-aspartate release was also blocked by mitogen-activated protein kinase kinase 1 inhibitors, implicating extracellular signal-regulated kinase (ERK)1/2 in {alpha}7 nAChR-evoked exocytosis. Western blotting confirmed that compound A, but not 5-iodo-A-85380, application increased ERK2 phosphorylation in PFC synaptosomes, and this was dependent on ryanodine-sensitive stores. Compound A also promoted synapsin-1 phosphorylation at ERK1/2-dependent sites, in a ryanodine-sensitive manner. Thus, β2* and {alpha}7 nAChR subtypes in the PFC mediate [3H]D-aspartate release via distinct mechanisms as a result of their differential coupling to VOCCs and Ca2+-induced Ca2+ release (CICR), respectively. The ability of {alpha}7 nAChRs to promote the phosphorylation of presynaptic ERK2 and synapsin-1, downstream of CICR, provides a potential mechanism for presynaptic facilitation in the PFC.


Received February 25, 2008; accepted April 28, 2008

Address correspondence to: Prof. Susan Wonnacott, Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, United Kingdom. E-mail: bsssw{at}bath.ac.uk







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics